BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34158547)

  • 21. Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
    Matsumoto K; Urabe Y; Oka S; Inagaki K; Tanaka H; Yuge R; Hayashi R; Kitadai Y; Arihiro K; Shimamoto F; Tanaka S; Chayama K
    Inflamm Bowel Dis; 2021 Apr; 27(5):686-696. PubMed ID: 33089869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case.
    Sada H; Shimomura M; Hinoi T; Egi H; Kawaguchi K; Yano T; Niitsu H; Saitou Y; Sawada H; Miguchi M; Adachi T; Ohdan H
    World J Surg Oncol; 2015 Mar; 13():123. PubMed ID: 25888857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis.
    Scarpa M; Castagliuolo I; Castoro C; Pozza A; Scarpa M; Kotsafti A; Angriman I
    World J Gastroenterol; 2014 Jun; 20(22):6774-85. PubMed ID: 24944468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of PD-1/PD-L1 imbalance in ulcerative colitis.
    Shi W; Zhang Y; Hao C; Guo X; Yang Q; Du J; Hou Y; Cao G; Li J; Wang H; Fang W
    PeerJ; 2023; 11():e15481. PubMed ID: 37273534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
    Sato A; MacHinami R
    Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA double-strand break repair of blood lymphocytes and normal tissues analysed in a preclinical mouse model: implications for radiosensitivity testing.
    Rübe CE; Grudzenski S; Kühne M; Dong X; Rief N; Löbrich M; Rübe C
    Clin Cancer Res; 2008 Oct; 14(20):6546-55. PubMed ID: 18927295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis.
    Fujii S; Tominaga K; Kitajima K; Takeda J; Kusaka T; Fujita M; Ichikawa K; Tomita S; Ohkura Y; Ono Y; Imura J; Chiba T; Fujimori T
    Gut; 2005 Sep; 54(9):1287-92. PubMed ID: 15870230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
    Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
    World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis.
    Osone K; Yokobori T; Katayama C; Takahashi R; Kato R; Tatsuski H; Takada T; Yajima R; Motegi Y; Ogawa H; Fujii T; Ojima H; Nakamura J; Yao T; Shirabe K; Kuwano H
    Oncol Lett; 2019 Nov; 18(5):4712-4718. PubMed ID: 31611980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
    AbdElazeem MA; El-Sayed M
    Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D receptor expression is associated with colon cancer in ulcerative colitis.
    Wada K; Tanaka H; Maeda K; Inoue T; Noda E; Amano R; Kubo N; Muguruma K; Yamada N; Yashiro M; Sawada T; Nakata B; Ohira M; Hirakawa K
    Oncol Rep; 2009 Nov; 22(5):1021-5. PubMed ID: 19787215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer.
    Kobayashi K; Tomita H; Shimizu M; Tanaka T; Suzui N; Miyazaki T; Hara A
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered phenotype of dextran sulfate sodium colitis in interferon regulatory factor-1 knock-out mice.
    Mannick EE; Cote RL; Schurr JR; Krowicka HS; Sloop GD; Zapata-Velandia A; Correa H; Ruiz B; Horswell R; Lentz JJ; Byrne P; Gastanaduy MM; Hornick CA; Liu Z
    J Gastroenterol Hepatol; 2005 Mar; 20(3):371-80. PubMed ID: 15740479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of PD-1 follows tumour development in the AOM/DSS model of inflammation-induced colorectal cancer in mice.
    Yassin M; Sadowska Z; Djurhuus D; Nielsen B; Tougaard P; Olsen J; Pedersen AE
    Immunology; 2019 Sep; 158(1):35-46. PubMed ID: 31429085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular profiling of ulcerative colitis-associated neoplastic progression.
    Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
    Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of costimulatory molecule CD80 in colonic dysplasia in ulcerative colitis: an immunosurveillance mechanism against colorectal cancer?
    Scarpa M; Behboo R; Angriman I; Cecchetto A; D'Incà R; Termini B; Barollo M; Ruffolo C; Polese L; Sturniolo GC; D'Amico DF
    Int J Colorectal Dis; 2006 Dec; 21(8):776-83. PubMed ID: 16520930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8
    Li YM; Yu JM; Liu ZY; Yang HJ; Tang J; Chen ZN
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4-NFκB signalling.
    Scarpa M; Cardin R; Bortolami M; Kotsafti A; Scarpa MC; Pozza A; Maran G; Picciocchi M; Ruffolo C; D'Incà R; Sturniolo GC; Castagliuolo I; Castoro C; Angriman I
    Eur J Cancer; 2013 Jan; 49(1):254-63. PubMed ID: 22704122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.